[A particular risk of prolonged immunosuppressive treatment: a case of acute myelomonocytic leukemia after chlorambucil treatment of severe rheumatoid arhtritis].
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy; D002273:Carcinogens; D002699:Chlorambucil / Q000009:adverse effects* / Q000627:therapeutic use; D004247:DNA; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D007938:Leukemia / Q000139:chemically induced / Q000209:etiology; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000209:etiology; D009691:Nucleic Acid Denaturation; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D002273:Carcinogens; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D004247:DNA
Un risque particulier au traitement immunodèpresseur prolongé: un cas de leucémie aigue myélo-monocytaire après traitement par le chlorambucil d'une polyarthrite rhymatoide sèvére